Personne

Caroline Vandevyver

Cette personne n’est plus à l’EPFL

Biographie

Caroline Vandevyver received her degree in biochemistry in 1985 from the Katholieke Universiteit Leuven, Belgium and her Ph.D. degree in biotechnology at the same university in 1989. She joined the Biomedical Research Institute "Dr. L- Willems Instituut" in Hasselt, Belgium, in 1989. Subsequently, she has worked there on T cell mediated autoimmune diseases (Multiple Sclerosis, Rheumatoid Arthritis), genetic association and linkage studies in multifactorial diseases, mutation analysis of genetic disorders (Phenylketonuria, alpha 1 anti-trypsine deficiency, congenital adrenal hyperplasia) and the development of active and passive immune therapies for cancer. She joined EPFL in 2000 at the Laboratory of Chemical Biotechnology headed by Prof. Ruth Freitag, where she was responsible for the cell culture lab and the (recombinant) protein purification and characterization. She joined the Laboratory of Lanthanide Supramolecular Chemistry (LCSL) in May 2006, where she was responsible for the live cell imaging project with Lanthanide complexes. In 2005, she joined the Office of the Research Commission. Her duties there were the management of national and international fellowship programs, the management of local research awards and the promotion of research performed at EPFL. In August 2013, she was nominated coordinator of the International Funding, one of the pillars of the Research Office at EPFL. Since January 2017, she is the Head of EPFL's Research Office.

À propos de ce résultat
Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.